Macular Degeneration :: USC biomedical team to participate in $6 million low vision project

An interdisciplinary team of biomedical researchers from the USC Viterbi School, the College and the Keck School of Medicine of USC has received a $6-million Bioengineering Research Partnership grant from the National Institutes of Health (NIH) to begin designing visual aids for millions of older adults who suffer from significant vision loss.

Eye :: NIH awards Phylonix phase II SBIR to develop zebrafish models for eye diseases

Phylonix Pharmaceuticals, Inc. today announced that it has been awarded a $1,092,031 Phase II Small Business Innovation Grant (SBIR) from the National Eye Institute of the National Institutes of Health (NIH) to develop zebrafish eye disease models for drug screening. The grant for “New Models for Eye Diseases” will support the Phylonix program over a period of three years.

Diabetes :: Diabetes drugs trials should measure outcomes important to patients

Most clinical trials for new diabetes drugs do not consider the impact medication will have on a patient’s quality of life or other outcomes that are important to patients, such as the risk of developing complications associated with diabetes, according to a Mayo Clinic commentary in the current issue of The Lancet.

Diabetes :: Novartis’ Galvus efficacious in treating patients with type 2 diabetes

Uncontrolled patients with type 2 diabetes treated with metformin, one of the most prescribed oral medicines for this disease, were four times more likely to achieve recommended blood sugar control levels by adding Galvus® (vildagliptin) to their treatment compared to those who added a placebo, according to new clinical data[1].

Glaucoma :: Glaucoma surgery in the blink of an eye

Prof. Ehud Assia, of Tel Aviv University?s Sackler School of Medicine is, quite simply, a rock star in the field of eye surgery. One of a small number of surgeons in the world who currently perform a complicated form of glaucoma surgery, Prof. Assia has developed a novel laser device that promises to revolutionize treatment of the disease.